Skip to content

Clinical Efficacy of Lingnan Fire Acupuncture in the Treatment of Somatic and Mental Symptoms in Herpes Zoster

Clinical Efficacy of Lingnan Fire Acupuncture in the Treatment of Somatic and Mental Symptoms in Herpes Zoster

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001699
Enrollment
Unknown
Registered
2026-07-06
Start date
2025-09-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes Zoster

Interventions

control group:Antiviral drug valaciclovir dispersible tablets
fire needle group:Lingnan fire acupuncture was used on the basis of oral western medicine treatment in the control group.

Sponsors

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18-80 years old; (2) Comply with the diagnostic criteria for herpes zoster in the 2022 Chinese Expert Consensus on Herpes Zoster of the Dermatologists Branch of the Chinese Medical Doctors' Association, and the diagnostic criteria for snake sores in the Diagnostic Efficacy Criteria for Traditional Chinese Medicine (TCM); (3) Within 7 days after herpes zoster rash; (4) Anxiety self-assessment scale (SAS) score = 69 and depression self-assessment scale (SDS) score = 72; (5) The patients themselves signed an informed consent form to participate in this trial voluntarily.

Exclusion criteria

Exclusion criteria: (1) Combined serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal and hematopoietic systems, and other organic lesions such as tumors, etc; (2) Those who have previous or current mental disorders such as depression and anxiety, those who are taking anti-anxiety and depression drugs in the past or at present, and those who cannot cooperate with the questionnaire because of mental or intellectual disabilities; (3) Those with significant coagulation disorders, patients with significant bleeding tendency or those with scarred body; (4) Pregnant and lactating women, and those who have had requests for childbirth in the past six months; (5) Those with known immunodeficiency status or history of infectious diseases such as AIDS or syphilis, history of hepatitis B antigen or hepatitis C antibody positivity, active tuberculosis, or those who have applied corticosteroids or immunosuppressants within 1 month; (6) belonging to special types of herpes zoster: ocular and auricular herpes zoster, tonic herpes zoster, atonic herpes zoster, anaplastic herpes zoster, herpes zoster meningitis or encephalitis, herpes zoster invasion of nerve fibers of the viscera, disseminated herpes zoster, and others (herpes zoster with herpetic, hemorrhagic, gangrenous, and other manifestations of herpes zoster); (7) Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
SF-McGill Pain Questionnaire;

Secondary

MeasureTime frame
Quantitative Chinese Medicine Symptom Score;Pain Visual Analogue Scale;Blister healing time;Scab formation time;Scab detachment time;Self-Rating Anxiety Scale;Self-Rating Depression Scale;Distress Management Screening Measure;Pittsburgh Sleep Quality Index;36-Item Short Form Survey;Postherpetic Neuralgia;

Countries

China

Contacts

Public ContactShuxin Wang

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

widiot@126.com13660285076

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026